| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2022 | Christopher Posner80 | President and CEO | Sell | 2,006 | $12.67 | $25,416.02 | -1.0% | -26.6% | -62.3% | |
| Apr 1, 2022 | Scott Terrillion90 | Sec'y; Chief Compliance & G.c. | Sell | 1,642 | $11.91 | $19,556.22 | -1.6% | -27.9% | -61.2% | |
| Apr 1, 2022 | Joana Goncalves86 | Chief Medical Officer | Sell | 1,642 | $11.91 | $19,556.22 | -2.1% | -27.9% | -61.2% | |
| Apr 1, 2022 | Frederique Ph.D. Menzaghi85 | Chief Scientific Officer,Svp-r& D | Sell | 1,784 | $11.91 | $21,247.44 | -1.0% | -27.9% | -61.2% | |
| Mar 3, 2022 | Thomas Charles Reilly | Chief Financial Officer | Sell | 2,044 | $11.38 | $23,260.72 | -5.1% | -24.7% | -7.2% | |
| Mar 3, 2022 | Scott Terrillion90 | Sec'y; Chief Compliance & G.c. | Sell | 1,787 | $11.38 | $20,336.06 | -1.7% | -24.7% | -7.2% | |
| Feb 25, 2022 | Frederique Ph.D. Menzaghi85 | Chief Scientific Officer,Svp-r& D | Sell | 2,114 | $10.29 | $21,753.06 | -1.2% | -23.4% | -4.1% | |
| Feb 25, 2022 | Joana Goncalves86 | Chief Medical Officer | Sell | 1,972 | $10.29 | $20,291.88 | -2.5% | -23.4% | -4.1% | |
| Feb 25, 2022 | Scott Terrillion90 | Sec'y; Chief Compliance & G.c. | Sell | 1,972 | $10.29 | $20,291.88 | -1.9% | -23.4% | -4.1% | |
| Nov 12, 2021 | Jeffrey L. Ives68 | Director | Sell | 8,180 | $16.04 | $131,207.20 | -53.2% | -35.7% | -31.8% |